The Largest Pharmaceutical Trade Show in Asia Returns to Shanghai in June 2026

Overview of CPHI and PMEC China 2026



The prestigious CPHI and PMEC China trade shows are set to make their grand return to the Shanghai New International Expo Centre (SNIEC) from June 16 to 18, 2026. This major event is part of a longstanding tradition in the industry, succeeding numerous successful editions over the years, positioned as a leading global destination for pharmaceutical ingredients and manufacturing solutions.

Expected to attract over 110,000 attendees and featuring more than 3,600 exhibitors from both local and international backgrounds, CPHI and PMEC China 2026 will present an unparalleled opportunity for sourcing, supply chain optimization, and innovation within the Chinese pharmaceutical sector. This event has solidified its reputation as the largest pharmaceutical showcase in Asia, underlining China’s importance in the global market.

China's Role in the Pharmaceutical Industry



The remarkable growth of the CPHI and PMEC China trade shows is a testament to China's standing as a global hub for pharmaceutical ingredients. The exhibitions offer a key marketplace for global products and solutions essential for modern medicine, encompassing active pharmaceutical ingredients (APIs), natural extracts, machinery, laboratory equipment, packaging innovations, biotechnology, and traditional Chinese medicine (TCM).

According to Orhan Caglayan, Executive Vice President of the pharmaceutical portfolio at Informa Markets, "The growth of CPHI and PMEC China reflects the extraordinary pace of innovation in China, reinforcing the country's position as a premier destination for resource acquisition, supply chain optimization, and strategic partnerships. The 2026 event is a testament to the resilience and vision of the pharmaceutical industry moving forward."

New Features and Expansions in 2026



The 2026 edition will expand its features, introducing dedicated zones including TCM pavilions and presentations focused on next-generation APIs. This expansion reflects two of China's core strengths: traditional ingredients and cutting-edge pharmaceutical advancements. Moreover, first-time exhibitors and specialized areas for aesthetic packaging in medicine, leading-edge technologies, and smart laboratory spaces will greatly enrich the event.

Participants will gain access to the highest concentration of pharmaceutical machinery manufacturers and the latest manufacturing technologies in Asia. Attendees can expect live demonstrations of equipment, technical seminars, and networking opportunities through programs like the Hosted Buyer Matchmaking Program and factory visits, which facilitate direct interactions between international buyers and leading suppliers.

With over 100 conferences and workshops led by more than 700 experts and representatives, participants will enjoy unmatched access to market insights and technical expertise. These sessions will place attendees at the forefront of rapid innovations, covering topics from research-phase medicines to developments in biotechnology and machinery.

A Unique Opportunity for Participants



Do not miss this unique global platform for sourcing from leading Chinese manufacturers, exploring TCM ingredients and natural extracts, assessing pharmaceutical equipment for manufacturing needs, partnering with contract manufacturers, networking, educating, and staying ahead of trends in pharmaceutical innovations. For more information and to register, visit CPHI China 2026.

CPHI and PMEC China 2026

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.